Atrial Fibrillation Clinical Trial
Official title:
WATCH Bleeding Episodes After Left Atrial Appendage Occlusion Versus Usual Care in Patients With Atrial FIBrillatIon and Severe to eNd-stage Chronic Kidney Disease (WatchAFIB in CKD)
The purpose of this study is to evaluate the superiority of left atrial appendage occlusion in comparison to oral anticoagulation with a vitamin K antagonist (INR 2-3) related to the frequency of occurrence of at least one bleeding classified as moderate or major within 24 months.
Open, randomized, controlled, multicenter clinical investigation. Transesophageal
echocardiography (TEE) for all patients within 14 days of the Enrolment Visit. Patients
randomized to oral anticoagulation (OAC) will receive standard of care (SOC) vitamin K
antagonist treatment throughout the 24 months clinical investigation period, managed by the
primary care physician, with the goal of achieving and maintaining an INR of 2-3 (INR
monitoring by the primary care physician every two weeks throughout study period).
Patients randomized to the WATCHMAN device will undergo device implantation within 48 hours
of the screening TEE and after confirmation of INR ≤ 1.7 in the catheterization laboratory
with a subsequent hospitalization for 24-48 hours.
Concomitant treatment with Aspirin/Clopidogrel (managed by the patient's primary care
physician) will be initiated on the day prior to device implantation, and will be continued
for 6 months after the procedure, at which time Clopidogrel will be discontinued;
administration of Aspirin will be continued indefinitely.
Follow-up visits for all patients will take place on Day 45, and at Month 6, Month 12 and
Month 24 (End of Study). Routine safety and efficacy assessments at each visit will be the
same for all patients regardless of treatment group.
Follow-up- visits at day 45, months 6, 12 and 24. Patients randomized to the WATCHMAN device
will have additional TEE imaging performed at the Day 45 and Month 6 visits.
An independent Data Monitoring Committee will monitor safety. A blinded and independent
Endpoint Committee will evaluate end-points throughout the entire study period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |